Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard ...
Non-GAAP Net Income Attributable to TAL Education Group (NYSE:TAL) -- $254.5 million, compared to $7.0 million YOY. Operating ...
U.S. Revenue -- $497,000, marking the first recorded U.S. commercial revenue for the company following FDA approval of CGuard ...
April 23, 2026. TAL Education Group beats earnings expectations. Reported EPS is $0.45, expectations were $0.14. Op ...
Acceptance Period Commences Today and Ends on May 9, 2026 Rumble Has Secured Commitments for Approximately 72% of the Outstanding Northern Data Shares and there is No Minimum Acceptance Threshold ...
Q1 Revenue of $704 million, an increase of 8% versus the prior year period; Q1 Net Revenue of $585 million, an increase of 4% ...
Following IDMC recommendation after interim futility analysis the decision was made to discontinue the TACTI-004 Phase III ...
Diverging issues across beef and pork, ranging from disease risk to trade volatility, may make chicken a more reliable source ...
Operational Strategy -- Management introduced a "family full life-cycle" model, integrating education, goods, and tourism ...
Operator: Good afternoon, ladies and gentlemen, and welcome to the Rimini Street Q1 2026 Earnings Conference Call. [Operator ...
This news release constitutes a 'designated news release” for the purposes of the prospectus supplement dated November 19, 2025 to the short form base shelf prospectus of Brookfield Infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results